Insider Transactions in Q3 2022 at 23and Me Holding Co. (ME)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2022
|
Neal Mohan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,633
+13.88%
|
-
|
|
Sep 06
2022
|
Richard H Scheller Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,633
+13.88%
|
-
|
|
Sep 06
2022
|
Roelof Botha Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,884
+7.43%
|
$17,884
$1.54 P/Share
|
|
Sep 06
2022
|
Patrick S Chung Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,047
+7.35%
|
$18,047
$1.54 P/Share
|
|
Sep 06
2022
|
Peter J. Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,633
+10.28%
|
-
|
|
Sep 06
2022
|
Sandra R Md Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,884
+5.84%
|
$17,884
$1.54 P/Share
|
|
Sep 06
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,210
+5.74%
|
$18,210
$1.54 P/Share
|
|
Sep 01
2022
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
129,761
+31.11%
|
-
|
|
Aug 25
2022
|
Sandra R Md Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,956
+21.77%
|
$70,956
$1.52 P/Share
|
|
Aug 25
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,576
+22.9%
|
$75,576
$1.52 P/Share
|
|
Aug 25
2022
|
Patrick S Chung Director |
BUY
Grant, award, or other acquisition
|
Direct |
76,566
+29.83%
|
$76,566
$1.52 P/Share
|
|
Aug 25
2022
|
Roelof Botha Director |
BUY
Grant, award, or other acquisition
|
Direct |
74,256
+29.12%
|
$74,256
$1.52 P/Share
|
|
Aug 25
2022
|
Richard H Scheller Director |
BUY
Grant, award, or other acquisition
|
Direct |
57,755
+43.12%
|
-
|
|
Aug 25
2022
|
Neal Mohan Director |
BUY
Grant, award, or other acquisition
|
Direct |
57,755
+43.12%
|
-
|
|
Aug 25
2022
|
Peter J. Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
57,755
+33.82%
|
-
|
|
Aug 24
2022
|
Kenneth J. Hillan Chief Therapeutics Officer |
SELL
Open market or private sale
|
Direct |
8,753
-4.27%
|
$26,259
$3.64 P/Share
|
|
Aug 20
2022
|
Steven J Schoch Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,782
-2.21%
|
$14,346
$3.33 P/Share
|
|
Aug 20
2022
|
Kenneth J. Hillan Chief Therapeutics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,628
-2.21%
|
$13,884
$3.33 P/Share
|
|
Aug 20
2022
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,628
-1.73%
|
$13,884
$3.33 P/Share
|
|
Aug 11
2022
|
Evan Lovell Director |
BUY
Other acquisition or disposition
|
Direct |
1,217,077
+49.77%
|
-
|